If GNTA does not have any drug due for a FDA approval in the next month or so, and all the news is out about the pipeline, then this stock should fall in a few days from today's high. The only other wild card that could be out there to cause this stock to go up is a buy out. Other than that, this baby should start going south once the conference in Chicago is over.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.